| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |